Business News >> Business >> Companies >> J
J News
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
Ad - Compare Up to 4 Free Offers. Home Refinance Inquiries Only.
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
This report is an insightful source for data, analysis and strategic insights into a Scope?s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
NEW YORK, Jan 9 (Reuters) - Merisant Worldwide Inc, a maker of low-calorie tabletop sweeteners such as Equal and Canderel, filed for Chapter 11 bankruptcy protection on Friday, weighed down by increased competition and too much debt. The closely-held,
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
NEW YORK, Jan 9 (Reuters) - Merisant Worldwide Inc, a maker of low-calorie tabletop sweeteners such as Equal and Canderel, filed for Chapter 11 bankruptcy protection on Friday, weighed down by increased competition and too much debt. The closely-held,
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
The appointment follows the resignation of Sy Naqvi, who served as president of Harley-Davidson Financial Services since February 2007. The company said Naqvi made a personal decision to resign. Bergmann will serve as interim president of the unit while
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
NEW YORK, Jan 9 (Reuters) - Merisant Worldwide Inc, a maker of low-calorie tabletop sweeteners such as Equal and Canderel, filed for Chapter 11 bankruptcy protection on Friday, under the weight of too much debt. The privately held Chicago-based company
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
NEW YORK, Jan 9 (Reuters) - Merisant Worldwide Inc, a maker of low-calorie tabletop sweeteners such as Equal and Canderel, filed for Chapter 11 bankruptcy protection on Friday, under the weight of too much debt. The privately held Chicago-based company
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
DUBLIN, Ireland--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/e5b7a4/the_top_five_globa A mini report identifying drivers and barriers to sustaining financial performance over the next 5 years for the top five global
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
DUBLIN, Ireland (Business Wire) -- Research and Markets (http://www.researchandmarkets.com/research/e5b7a4/the_top_five_globa) has announced the addition of the 'The Top Five Global Pharma Companies; Where they are Now and Where they heading?' report to
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
Research and Markets: DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/e5b7a4/the_top_five_globa) has announced the addition of the '' report to their offering. A mini report identifying drivers and
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
(BUSINESS WIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/e5b7a4/the_top_five_globa) has announced the addition of the 'The Top Five Global Pharma Companies; Where they are Now and Where they heading?' report to their offering.
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
Johnson & Johnson to Acquire Mentor Corporation: Expanding Presence in the Aesthetic Devices Market Summary Acquiring and partnering to expand product portfolio, strengthen R&D pipeline and venture into newer markets is a trend that's definitely not new.
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
Alkermes, Inc. (NASDAQ: ALKS) today announced that its partner, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), has initiated a phase 1 study of a four-week long-acting injectable formulation of risperidone for the treatment of
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
-- Wall Street News Alert's 'stocks to watch' this morning are: Applied Nanoscience Inc. (Other OTC:APNN.PK - News), Johnson & Johnson (NYSE:JNJ - News), Bristol-Myers Squibb Company (NYSE:BMY - News) and Honeywell International Incorporated (NYSE:HON -
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
DUBLIN, Ireland--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/e137e7/johnson_johnson Johnson & Johnson to Acquire Mentor Corporation: Expanding Presence in the Aesthetic Devices Market Summary Acquiring and
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
DUBLIN, Ireland (Business Wire) -- Research and Markets (http://www.researchandmarkets.com/research/e137e7/johnson_johnson) has announced the addition of GlobalData 's new company profile 'Johnson & Johnson to Acquire Mentor Corporation: Expanding
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
- Alkermes, Inc. (NASDAQ: ALKS) today announced that its partner, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), has initiated a phase 1 study of a four-week long-acting injectable formulation of risperidone for the treatment
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Alkermes, Inc. (NASDAQ: ALKS) today announced that its partner, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), has initiated a phase 1 study of a four-week long-acting injectable formulation
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
(BUSINESS WIRE) -- Alkermes, Inc. (: Last: Delayed quote data Analyst Create alert Insider Discuss Financials , , ) today announced that its partner, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), has initiated a phase 1 study
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
Stocks discussed in the in-depth session of Jim Cramers Mad Money TV program, Thursday January 8. Donny Deutsch: Madoff is a Serial Killer Donny Deutsch, host of CNBCs The Big Idea called Bernie Madoff a serial killer who belongs in a cage tomorrow. He
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
Jan 9 (Reuters) - The following were the top stories in The Wall Street Journal on Friday. Reuters has not verified these stories and does not vouch for their accuracy. * Lehman Brothers Holdings Inc's private-equity arm has reached a deal with its
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
Jan 9 (Reuters) - Vanderbilt University will team up with Johnson & Johnson (JNJ.N: Quote, Profile, Research) to develop new drugs to treat schizophrenia, according to a media report. The Tennessee university will receive about $10 million from
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
The FDA has requested a risk evaluation mitigation strategy from Eli Lilly for Zyprexa Adhera. Following the FDA's complete response letter for the drug, Eli Lilly has begun preparing a proposed risk evaluation mitigation strategy for Zyprexa Adhera.
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
Jan 9 (Reuters) - Vanderbilt University will team up with Johnson & Johnson to develop new drugs to treat schizophrenia, according to a media report. The Tennessee university will receive about $10 million from J&J over the next three years, plus as much
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
Jan 9 (Reuters) - Vanderbilt University will team up with Johnson & Johnson (JNJ.N The Tennessee university will receive about $10 million from J&J over the next three years, plus as much as $100 million in additional payments if it meets certain
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
Extract not available.
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
LONDON (Reuters) - Antipsychotic drugs prescribed to treat aggression in older Alzheimer's patients appear to significantly raise their risk of dying prematurely, British researchers said Friday. The results from the first long-term study on the effect
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
LONDON (Reuters) - Antipsychotic drugs prescribed to treat aggression in older Alzheimer's patients appear to significantly raise their risk of dying prematurely, British researchers said Friday. The results from the first long-term study on the effect
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
BabyCenter LLC is closing its online store after 10 years of selling products such as toys, children's clothing, formula and other products for parents and parents-to-be. BabyCenter.com, which is owned by Johnson & Johnson, is going to shift its focus to
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
The company is a subsidiary of New Brunswick, N.J.-based Johnson & Johnson Vision Care, and manufactures Acuvue-brand disposable contact lenses. It has a local workforce of about 2,000, according to staff reports. An e-mail response to an inquiry about
Moreover Technologies - Johnson and Johnson news - 30 of 560 returned
-- Harley-Davidson, Inc. announced today that its Chief Financial Officer, Tom Bergmann, will take on the added responsibility of interim President of Harley-Davidson Financial Services (HDFS), effective immediately. The appointment follows HDFS
Moreover Technologies - JP Morgan news - 30 of 1442 returned
Ad - Compare Up to 4 Free Offers. Home Refinance Inquiries Only.
Moreover Technologies - JP Morgan news - 30 of 1442 returned
Extract not available.
Moreover Technologies - JP Morgan news - 30 of 1442 returned
Extract not available.
Moreover Technologies - JP Morgan news - 30 of 1442 returned
CARLSBAD, Calif., Jan. 8 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced that the Company will present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Stanley T. Crooke, M.D., Ph. D., Chairman and
Moreover Technologies - JP Morgan news - 30 of 1442 returned
LOUISVILLE, Ky., Jan. 9 /PRNewswire-FirstCall/ -- Almost Family, Inc. (AFAM), a leading regional provider of home health nursing services, announced today that Steve Guenthner, Senior Vice President and Chief Financial Officer, is scheduled to present at
Moreover Technologies - JP Morgan news - 30 of 1442 returned
LOUISVILLE, Ky., Jan. 9 KY-AlmostFamily LOUISVILLE, Ky., Jan. 9 /PRNewswire-FirstCall/ -- Almost Family, Inc. (Nasdaq: AFAM), a leading regional provider of home health nursing services, announced today that Steve Guenthner , Senior Vice President and
Moreover Technologies - JP Morgan news - 30 of 1442 returned
LOUISVILLE, Ky., Jan. 9 /PRNewswire-FirstCall/ -- Almost Family, Inc. (Nasdaq: AFAM), a leading regional provider of home health nursing services, announced today that Steve Guenthner, Senior Vice President and Chief Financial Officer, is scheduled to
Moreover Technologies - JP Morgan news - 30 of 1442 returned
/PRNewswire-FirstCall via COMTEX/ -- Almost Family, Inc. (: Last: Delayed quote data Analyst Create alert Insider Discuss Financials , , ) , a leading regional provider of home health nursing services, announced today that Steve Guenthner, Senior Vice
Moreover Technologies - JP Morgan news - 30 of 1442 returned
LOUISVILLE, Ky., Jan. 9 /PRNewswire-FirstCall/ --Almost Family, Inc. , a leading regional provider of home health nursing services, announced today that Steve Guenthner, Senior Vice President and Chief Financial Officer, is scheduled to present at the
Moreover Technologies - JP Morgan news - 30 of 1442 returned
LOUISVILLE, Ky., Jan. 9 /PRNewswire-FirstCall/ -- Almost Family, Inc. (Nasdaq: AFAM - News), a leading regional provider of home health nursing services, announced today that Steve Guenthner, Senior Vice President and Chief Financial Officer, is
Moreover Technologies - JP Morgan news - 30 of 1442 returned
JPMorgan downgrades AGCO Corp. (NYSE: AG) from Overweight to Neutral. AGCO Corporation manufactures and distributes agricultural equipment and related replacement parts worldwide.
Moreover Technologies - JP Morgan news - 30 of 1442 returned
JPMorgan downgrades Cosan Ltd. (NYSE: CZZ) from Overweight to Neutral. Cosan Limited, through its subsidiaries, engages in the manufacture and sale of sugar and ethanol primarily in Brazil.
Moreover Technologies - JP Morgan news - 30 of 1442 returned
Extract not available.
Moreover Technologies - JP Morgan news - 30 of 1442 returned
KENILWORTH, N.J., Jan. 9 /PRNewswire-FirstCall/ -- Schering-Plough Corporation will provide a live audio webcast of a presentation by Thomas P. Koestler, Ph. D., executive vice president and president, Schering-Plough Research Institute, at the 27th
Moreover Technologies - JP Morgan news - 30 of 1442 returned
CHADDS FORD, Pa., Jan. 9 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals announced today that David Holveck, President and Chief Executive Officer of Endo, will present a corporate update at the J.P. Morgan 27th Annual Healthcare Conference on
Moreover Technologies - JP Morgan news - 30 of 1442 returned
LOS ALTOS, Calif., Jan. 8 /PRNewswire/ -- InteKrin Therapeutics, Inc., will present at the 27th Annual JP Morgan Global Healthcare Conference at 9:00 a.m. Pacific Time on Tuesday, January 13, 2009, to be held at the Westin St. Francis in San Francisco,
Moreover Technologies - JP Morgan news - 30 of 1442 returned
PARIS -(Dow Jones)- JPMorgan Asset Management's stake in French IT company Bull SA (BULL.FR) has fallen through the 5% threshold to 1.72%, according to a filing Friday with French stock market watchdog AMF. According to the filing, JPMorgan Asset
Moreover Technologies - JP Morgan news - 30 of 1442 returned
PARIS -(Dow Jones)- JPMorgan Asset Management's stake in French IT company Bull SA (BULL.FR) has fallen through the 5% threshold to 1.72%, according to a filing Friday with French stock market watchdog AMF. According to the filing, JPMorgan Asset
Moreover Technologies - JP Morgan news - 30 of 1442 returned
Thomson Reuters 2009 All rights reserved
Moreover Technologies - JP Morgan news - 30 of 1442 returned
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that it will present at the JPMorgan Healthcare Conference on Thursday, January 15, 2009. Mr. Ron Lowy, Chief Executive Officer and Mr. Stanley Lapidus,
Moreover Technologies - JP Morgan news - 30 of 1442 returned
(BUSINESS WIRE) -- Helicos BioSciences Corporation (: Last: Delayed quote data Analyst Create alert Insider Discuss Financials , , ) announced today that it will present at the JPMorgan Healthcare Conference on Thursday, January 15, 2009. Mr. Ron Lowy,
Moreover Technologies - JP Morgan news - 30 of 1442 returned
Helicos BioSciences Corporation HLCS announced today that it will present at the JPMorgan Healthcare Conference on Thursday, January 15, 2009. Mr. Ron Lowy, Chief Executive Officer and Mr. Stanley Lapidus, Chairman will present at 10:30 a.m. Pacific
Moreover Technologies - JP Morgan news - 30 of 1442 returned
Alliance Imaging, Inc. AIQ, a leading national provider of outpatient diagnostic imaging and radiation therapy services, announced that Paul S. Viviano, Chairman of the Board and Chief Executive Officer, and Howard K. Aihara, Executive Vice President and
Moreover Technologies - JP Morgan news - 30 of 1442 returned
Extract not available.
Moreover Technologies - JP Morgan news - 30 of 1442 returned
NEWPORT BEACH, Calif. -- (Business Wire) Alliance Imaging, Inc. (NYSE:AIQ), a leading national provider of outpatient diagnostic imaging and radiation therapy services, announced that Paul S. Viviano, Chairman of the Board and Chief Executive Officer,
Moreover Technologies - JP Morgan news - 30 of 1442 returned
J.P. Morgan upgrades Centene (NYSE: CNC) from Underweight to Neutral. Centene Corporation is a multi-line healthcare enterprise operating primarily in two segments: Medicaid Managed Care and Specialty Services.
Moreover Technologies - JP Morgan news - 30 of 1442 returned
J.P. Morgan upgrades Chevron (NYSE: CVX) from Neutral to Overweight. Chevron Corp. manages its investments in subsidiaries and affiliates, and provides administrative, financial, management and technology support to the United States and International
Moreover Technologies - JP Morgan news - 30 of 1442 returned
Extract not available.
Moreover Technologies - JP Morgan news - 30 of 1442 returned
J.P. Morgan downgrades PetroChina (NYSE: PTR) from Overweight to Neutral. PetroChina Company Limited (PetroChina) is a producer of crude oil and natural gas in China.
Moreover Technologies - JP Morgan news - 30 of 1442 returned
J.P. Morgan downgrades Marathon Oil (NYSE: MRO) from Overweight to Neutral. Marathon Oil Corporation is engaged in the business of exploration, development and production activities in 11 countries.
Moreover Technologies - JP Morgan news - 30 of 1442 returned
CAMBRIDGE, Mass., Jan. 9, 2009 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NasdaqGM:MNTA - News), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Craig Wheeler, Chief Executive
| ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
